At the time of writing, Disc Medicine Inc [IRON] stock is trading at $55.0, up 6.42%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IRON shares have gain 5.73% over the last week, with a monthly amount glided 14.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On November 05, 2024, upgrade upgraded it’s rating to Overweight but maintained its price target of $85 on the stock. Raymond James upgraded its rating to a Strong Buy and increased its price target to $110 on November 04, 2024. Jefferies initiated its recommendation with a Buy and recommended $89 as its price target on October 23, 2024. In a note dated August 22, 2024, Wells Fargo initiated an Overweight rating and provided a target price of $75 on this stock.
For the past year, the stock price of Disc Medicine Inc fluctuated between $30.82 and $68.73. Currently, Wall Street analysts expect the stock to reach $72.5 within the next 12 months. Disc Medicine Inc [NASDAQ: IRON] shares were valued at $55.0 at the most recent close of the market. An investor can expect a potential return of 31.82% based on the average IRON price forecast.
Analyzing the IRON fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.23 and Total Capital is -0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 52.22 points at the first support level, and at 49.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 56.40, and for the 2nd resistance point, it is at 57.80.
Ratios To Look Out For
It is important to note that Disc Medicine Inc [NASDAQ:IRON] has a current ratio of 37.65. In addition, the Quick Ratio stands at 37.65 and the Cash Ratio stands at 6.55.
Transactions by insiders
Recent insider trading involved Franchi Jean M., Chief Financial Officer, that happened on Jun 16 ’25 when 2000.0 shares were sold. Officer, JEAN FRANCHI completed a deal on Jun 16 ’25 to buy 2000.0 shares. Meanwhile, Chief Medical Officer Savage William Jacob sold 2996.0 shares on Jun 06 ’25.
